This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
The ASCO Post
ascopost.bsky.social
did:plc:km6ed4kyyj5hkysfzffqm3vw
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell RCC led to extended median PFS without compromising safety.
The median systemic therapy–free survival was 34 months.
Insights from Chad Tang, MD, et al here: https://ascopost.com/news/september-2025/metastasis-directed-radiotherapy-for-oligometastatic-clear-cell-renal-cell-carcinoma/
2025-09-30T18:03:21.254Z